reslizumab: Clinical Trials

7 trials of reslizumab, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 1 recruiting. 7 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 27Completed 6, Recruiting 1
Phase 32Completed 2

Follow reslizumab: new trials by email Literature Review of reslizumab trials Research Report on reslizumab

Trials (filtered) newest first · largest first

All 7 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reslizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis (EGPA) Study
Reslizumab - Asthma
Phase 2RecruitingNational Jewish Health102017-09-122017-09-14
Reslizumab in Patients With Severe Asthma Who Failed to Respond to Omalizumab
Reslizumab - Severe Asthma
Phase 2CompletedSociedad Española de Neumología y Cirugía Torácica302017-04-202018-05-16
Anti-Interleukin-5 (IL5) Monoclonal Antibody (MAb) in Prednisone-dependent Eosinophilic Asthma
Reslizumab, Placebo - Severe Persistent Asthma, Eosinophilic Bronchitis
Phase 2 / Phase 3CompletedMcMaster University102015-10-012018-04-04
Reslizumab to Prevent Post-treatment Eosinophilia in Loiasis
Reslizumab, Diethylcarbamazine, Placebo - Loiasis
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)312010-04-012022-01-27
Efficacy and Safety Study of Reslizumab to Treat Poorly Controlled Asthma
Reslizumab, Saline - Asthma
Phase 2CompletedCeption Therapeutics1062008-04-012016-08-17
Efficacy and Safety Study of Reslizumab to Treat Eosinophilic Esophagitis in Subjects Aged 5 to 18 Years
Reslizumab, Saline - Eosinophilic Esophagitis
Phase 2 / Phase 3CompletedCeption Therapeutics2272008-03-012016-09-02
Anti-Interleukin-5 Antibody to Treat Hypereosinophilic Syndrome
SCH55700 - Hypereosinophilic Syndrome
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)102001-06-012008-03-04

Conditions studied

Asthma (4)  ·  Eosinophilia (1)  ·  Eosinophilic Esophagitis (1)  ·  Filariasis (1)  ·  Gastroesophageal Reflux (1)  ·  Hypereosinophilic Syndrome (1)  ·  Loiasis (1)

Sponsors

Ception Therapeutics (2)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  McMaster University (1)  ·  National Jewish Health (1)  ·  Sociedad Española de Neumología y Cirugía Torácica (1)

Countries

United States (5)  ·  Canada (3)  ·  Spain (1)

Top investigators

Amy D Klion, M.D. (1)  ·  Michael Wechsler, MD (1)  ·  Parameswaran Nair, MD, PhD (1)

Results publications

PMID 22206777, PMID 28915080, PMID 33548468